(R)-Citalopram Oxalate,
219861-53-7,
UNII-LQ4I38573N,
LQ4I38573N,
(R)-1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate,
Citalopram oxalate, (R)-,
R-(-)-Citalopram oxalate,
CTK8F0585,
DTXSID00661872,
(1R)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid,
AKOS015961781,
AC-3393,
API0000096,
BC208260,
RT-011864,
FT-0665067,
EN300-196576,
J-014395,
UNII-B5RDX2419X component KTGRHKOEFSJQNS-VEIFNGETSA-N,
(-)-(R)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate,
(1R)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; oxalic acid,
1-(3-Dimethylaminopropyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile Oxalate,
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1R)-, ethanedioate (1:1),
Oxalic acid--(1R)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile (1/1),
Escitalopram oxalate,
R-Citalopram Oxalate,
CS-O-11057,
219861-08-2,